Clinical Trial Update: A Multi-Center Observational Surveillance Study of VAP Causing Bacteria

View source ↗

Summary

A multi-center observational surveillance study of bacteria causing ventilator-associated pneumonia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Ventilator Associated Pneumonia | Status: COMPLETED